Neuralink Officially Approved by the U.S.: Brain Chip to Be Implanted in Second Patient Soon

Elon Musk’s brain chip development company, Neuralink, has received approval from the U.S. Food and Drug Administration (FDA) for its second human trials. The FDA gave the green light after the company assured that it would address the issues encountered in the first trial.
Neuralink Officially Approved by the U.S.

Neuralink Secures FDA Approval for Second Human Trial

Elon Musk‘s brain chip venture, Neuralink, began its first human trials a few months ago. In January, a 29-year-old paralyzed man named Noland Arbaugh became the first person to have a chip implanted in his brain. Subsequent videos showed Arbaugh being able to do many things, from playing games to posting on social media, using only the power of thought.

Now, there has been a development that will please Neuralink. The U.S. Food and Drug Administration (FDA) has officially approved the company to continue its tests. This news was revealed in a report published by the Wall Street Journal (WSJ).

Second Neuralink Chip to be Implanted in Another Person

The FDA’s approval came after the company assured that it would address the issues encountered in the initial trials. The company recently disclosed that there were some problems with the positioning of the threads in the chip implanted in Arbaugh. They plan to resolve these issues by placing the threads deeper.

It is not yet known who the second patient to receive the Neuralink chip will be. The company is expected to begin its second trial in June. It also aims to implant the device in a total of 10 people by the end of the year. According to WSJ, over 1,000 paralyzed individuals have applied for the trials so far.

Neuralink’s brain-computer interface system aims to enable the control of devices such as computers through thought, thereby helping paralyzed patients.

Scroll to Top